Oncology

Oncology

track_changes Track Tracking Be alerted when new articles are added in this gateway (manage your tracking alerts via your account) Stop tracking this gateway
161-180 of 262 ARTICLES
https://doi.org/10.12688/f1000research.126462.1
Research Article metrics
PD-L1 expression as predictor of immunotherapy eligibility in penile squamous cell carcinoma patients
[version 1; peer review: 1 approved, 1 approved with reservations, 1 not approved]
Peer Reviewers Thomas S. Gerald; Jan Hrudka; Dr.Sourav Kumar Mishra
PUBLISHED 09 Nov 2022
https://doi.org/10.12688/f1000research.55004.2
Research Article metrics
Revised
Changes in mammography screening in Ontario and Alberta following national guideline dissemination: an interrupted time series analysis
[version 2; peer review: 2 approved]
Peer Reviewers Sisse Helle Njor; Jacqueline M. Hirth, Judith Gutierrez and Tiffany Ostovar-Kermani
  • Funder
  • Canadian Institutes of Health Research
LATEST VERSION PUBLISHED 07 Nov 2022
https://doi.org/10.12688/f1000research.122220.2
Case Report metrics
Revised
Case Report: Severe gastrointestinal bleeding revealing metastatic multifocal gastrointestinal angiosarcoma
[version 2; peer review: 1 approved, 1 approved with reservations]
Peer Reviewers Meriam Sabbah; Gabriel Perlemuter
LATEST VERSION PUBLISHED 07 Nov 2022
https://doi.org/10.12688/f1000research.126337.1
Review metrics
Role of RAS signaling in ovarian cancer
[version 1; peer review: 2 approved]
Peer Reviewers Shams Tabrez; Haider Raza and Annie John
  • Funder
  • Medical Research center, Hamad Medical Corporation
PUBLISHED 04 Nov 2022
https://doi.org/10.12688/f1000research.126905.1
Case Report metrics
Case Report: A pericardial effusion secondary to cardiac desmoplastic small round cell tumor
[version 1; peer review: 2 approved with reservations]
Peer Reviewers Fernand Bteich; Madelyn Espinosa-Cotton
PUBLISHED 28 Oct 2022
https://doi.org/10.12688/f1000research.110031.1
Research Article metrics
Evaluation of PD-L1 expression in vulvar cancer
[version 1; peer review: 1 not approved]
Peer Reviewers Tao Chang
PUBLISHED 27 Oct 2022
https://doi.org/10.12688/f1000research.122814.1
Research Article metrics
Predictive value of 18F-fluorodeoxyglucose accumulation in visceral fat activity to detect colorectal cancer metastases (prospective observational cohort study)
[version 1; peer review: 2 approved]
Peer Reviewers Jandos Amankulov; Marianie Musarudin
PUBLISHED 10 Oct 2022
https://doi.org/10.12688/f1000research.125335.1
Case Report metrics
Case Report: Localized Ewing’s sarcoma of the scapula in an adult
[version 1; peer review: 1 approved with reservations]
Peer Reviewers Iyad Sultan
PUBLISHED 10 Oct 2022
https://doi.org/10.12688/f1000research.43590.2
Research Article metrics
Revised
Associated predictor covariates of cervical cancer stage and impact on survival at Khartoum oncology hospital, Sudan
[version 2; peer review: 2 approved]
Peer Reviewers Nazik Hammad; Elvynna Leong and Ong Sok King
LATEST VERSION PUBLISHED 07 Oct 2022
https://doi.org/10.12688/f1000research.121785.2
Case Report metrics PEER REVIEW DISCONTINUED
Revised
Case Report: Nasopharyngeal carcinoma has metastasis to the orbit, consequences in anaemia: A paediatric unusual case of Bangladesh.
[version 2; peer review: 1 approved]
Peer Reviewers Muhtarum Yusuf
LATEST VERSION PUBLISHED 30 Sep 2022
https://doi.org/10.12688/f1000research.125428.1
Research Article metrics AWAITING PEER REVIEW
Factors predicting complications, neurologic deterioration and mortality for patients with meningioma surgery: An observational study
[version 1; peer review: awaiting peer review]
Peer Reviewers Invited
PUBLISHED 27 Sep 2022
https://doi.org/10.12688/f1000research.122434.2
Case Report metrics
Revised
Case Report: Focal leptomeningeal disease, atypical cancer of unknown primary site
[version 2; peer review: 2 approved]
Peer Reviewers Miguel Oswaldo Cadena-Sanabria; José Percy Amado Tineo
LATEST VERSION PUBLISHED 21 Sep 2022
https://doi.org/10.12688/f1000research.109417.1
Research Article metrics
An observational cross-sectional study on breast cancer patients’ knowledge of their disease: A likely cause of depression and anxiety
[version 1; peer review: 1 approved with reservations]
Peer Reviewers Paula Poikonen-Saksela
PUBLISHED 02 Sep 2022
https://doi.org/10.12688/f1000research.76187.2
Research Article metrics
Revised
Anticancer activity of Caesalpinia sappan by downregulating mitochondrial genes in A549 lung cancer cell line
[version 2; peer review: 2 approved]
Peer Reviewers Yi Li; Jayarani Fatimah Putri
  • Funder
  • Kementerian Riset dan Teknologi /Badan Riset dan Inovasi Nasional
LATEST VERSION PUBLISHED 25 Aug 2022
https://doi.org/10.12688/f1000research.121639.1
Case Report metrics
Case Report: A rare presentation of prostate cancer with peritoneal carcinomatosis and malignant ascites complicated by tumor lysis syndrome
[version 1; peer review: 1 approved with reservations]
Peer Reviewers Tomislav Omrčen
PUBLISHED 18 Aug 2022
https://doi.org/10.12688/f1000research.108827.2
Research Article metrics
Revised
Assessing the anticancer effects of metformin
[version 2; peer review: 3 approved with reservations, 3 not approved]
Peer Reviewers Deqiang Huang; Divya Subramonian; Kasuni H.M. Akalanka; Sabyasachi Banerjee; Janaina Fernandes; HALIMAT AMIN ABDULRAHIM and Modinah Abdul Raheem
LATEST VERSION PUBLISHED 09 Aug 2022
https://doi.org/10.12688/f1000research.122871.1
Research Article metrics
Managing the effect of magnetic resonance imaging pulse sequence on radiomic feature reproducibility in the study of brain metastases
[version 1; peer review: 1 approved with reservations]
Peer Reviewers Nguyen Quoc Khanh Le
  • Funder
  • MD Anderson - CCSG Radiation Oncology and Cancer Imaging Program Grant
PUBLISHED 04 Aug 2022
https://doi.org/10.12688/f1000research.123884.1
Study Protocol metrics
The burden of BRCA1 and BRCA2 gene mutations among Vietnamese women and their associated factors: A protocol for a systematic review and meta-analysis
[version 1; peer review: 1 not approved]
Peer Reviewers Weang Kee Ho and Boon Hong Ang
PUBLISHED 28 Jul 2022
https://doi.org/10.12688/f1000research.110268.2
Research Article metrics
Revised
Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain
[version 2; peer review: 2 approved]
Peer Reviewers Manushak Avagyan; Durga Neupane
  • Funder
  • Sociedad Española de Oncología Médica
LATEST VERSION PUBLISHED 26 Jul 2022
https://doi.org/10.12688/f1000research.122368.1
Case Report metrics
Case Report: Ovarian fibroma: typical presentation with Meigs’s Syndrome
[version 1; peer review: 2 approved, 1 approved with reservations]
Peer Reviewers Irene Iavarone; Bijal Patel; Heera Shenoy
PUBLISHED 22 Jul 2022
161-180 of 262 ARTICLES
Gateway Areas
Our News
  • Advances in Fibroblast Research launch

    Article collection open for submissions, led by Guest Advisor Dr Matthew Buechler. Submission deadline: 5th October 2023. For more information, contact krishna.sharma@f1000.com.

  • Childhood Cancer launch

    Article collection open for submissions, led by Guest Advisor Dr Ana Banito. Submission deadline: 2nd June 2023. For more information, contact krishna.sharma@f1000.com.

  • Bioinformatics in Cancer Research launch

    Article collection open for submissions, led by Guest Advisors Dr Jacob Luber, Dr Rongling Wu and Dr Li Zhang. Submission deadline: 30th November 2022. For more information, contact vinitha.raghavan@f1000.com.

  • Equitable Cancer Care launch

    Article collection open for submissions, led by Guest Advisor Dr. Matthew Schabath. For more information, contact krishna.sharma@f1000.com.

  • Radiomics launch

    Article collection open for submission, led by Guest Advisor Dr Alberto Traverso. For more information, contact krishna.sharma@f1000.com.

Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.